Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 94 of the 105 references it cites were found in a registry or an index.

A hybrid quantum computing pipeline for real world drug discovery

Open access

Abstract

Quantum computing, with its superior computational capabilities compared to classical approaches, holds the potential to revolutionize numerous scientific domains, including pharmaceuticals. However, the application of quantum computing for drug discovery has primarily been limited to proof-of-concept studies, which often fail to capture the intricacies of real-world drug development challenges. In this study, we diverge from conventional investigations by developing a hybrid quantum computing pipeline tailored to address genuine drug design problems. Our approach underscores the application of quantum computation in drug discovery and propels it towards more scalable system. We specifically construct our versatile quantum computing pipeline to address two critical tasks in drug discovery: the precise determination of Gibbs free energy profiles for prodrug activation involving covalent bond cleavage, and the accurate simulation of covalent bond interactions. This work serves as a pioneering effort in benchmarking quantum computing against veritable scenarios encountered in drug design, especially the covalent bonding issue present in both of the case studies, thereby transitioning from theoretical models to tangible applications. Our results demonstrate the potential of a quantum computing pipeline for integration into real world drug design workflows.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-024-67897-8

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic demonstration for the generalizable quantum computing pipeline for drug discovery. (a) The standard workflow of computer-aided drug design (CADD). (b) The module detailing the quantum computing process involved.
Figure 1 Schematic demonstration for the generalizable quantum computing pipeline for drug discovery. (a) The standard workflow of computer-aided drug design (CADD). (b) The module detailing the quantum computing process involved.CC BY · PubMed Central
Figure 2 Schematic illustration of components(4, 5, 6 and TS) involved in the process of the C-C bond cleavage-based activated drug release. For ease of comparison, we have adopted the molecular numbering from the original work of carbon-carbon bond cleavage based prodrug activation strategy.
Figure 2 Schematic illustration of components(4, 5, 6 and TS) involved in the process of the C-C bond cleavage-based activated drug release. For ease of comparison, we have adopted the molecular numbering from the original work of carbon-carbon bond cleavage based prodrug activation strategy.CC BY · PubMed Central
Figure 3 The 2-qubit quantum circuit used in this study. The state of the quantum circuit is adjusted by 4 parameterized Ry gates.
Figure 3 The 2-qubit quantum circuit used in this study. The state of the quantum circuit is adjusted by 4 parameterized Ry gates.CC BY · PubMed Central
Figure 4 Left: the KRAS-Sotorasib bonded structure. The cystein-Sotorasib part is shown as sticks while the rest of the system as ribbons. Right: choosing the QM region. The atoms labeled SG, C18, C17, O16, and C15 are chosen.
Figure 4 Left: the KRAS-Sotorasib bonded structure. The cystein-Sotorasib part is shown as sticks while the rest of the system as ribbons. Right: choosing the QM region. The atoms labeled SG, C18, C17, O16, and C15 are chosen.CC BY · PubMed Central
Figure 5 (a) Energy evolution during the MD simulation. The energy stabilized after an initial equilibrating phase. (b) Monitoring the QM region energy evolution. (c) The covalent bond is remarkably stable during the whole simulation process. The bond length fluctuates around 1.86 Angstrom with a standard deviation less than 0.1 Angstrom. The bond length is aligned with previous literature discoveries, and the small deviation is a good indication of the bonding stability.(d) Visualising the bond angle variations during the simulation (CB-SG-C18 and SG-C18-C17).
Figure 5 (a) Energy evolution during the MD simulation. The energy stabilized after an initial equilibrating phase. (b) Monitoring the QM region energy evolution. (c) The covalent bond is remarkably stable during the whole simulation process. The bond length fluctuates around 1.86 Angstrom with a standard deviation less than 0.1 Angstrom. The bond length is aligned with previous literature discoveries, and the small deviation is a good indication of the bonding stability.(d) Visualising the bond angle variations during the simulation (CB-SG-C18 and SG-C18-C17).CC BY · PubMed Central
Figure 6 Energy transition of the classical simulation(in blue), the noiseless quantum emulation (in orange), and the quantum computer simulation(in green). The fluctuation falls neatly in the permissible deviations of the molecular dynamics simulation.
Figure 6 Energy transition of the classical simulation(in blue), the noiseless quantum emulation (in orange), and the quantum computer simulation(in green). The fluctuation falls neatly in the permissible deviations of the molecular dynamics simulation.CC BY · PubMed Central
Figure 7 Moving key computation to the quantum computer. Left: the simulation is started on a quantum computer, and then moved to a classical machine. Right: the simulation is started on a classical machine, moved to a quantum computer halfway, and then moved back to a classical computer.
Figure 7 Moving key computation to the quantum computer. Left: the simulation is started on a quantum computer, and then moved to a classical machine. Right: the simulation is started on a classical machine, moved to a quantum computer halfway, and then moved back to a classical computer.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 105 references

Research works printed but not linked: 2

  1. Levine, I. N., Busch, D. H. & Shull, H. Quantum chemistry Vol. 6 (Pearson Prentice Hall, 2009).
  2. Robert, A., Barkoutsos, P. K., Woerner, S. & Tavernelli, I. Resource-efficient quantum algorithm for protein folding. npj Quantum Inf. 7, 38 (2021). · DOI · Paper page

Cited by

See all 67

Metadata

Authors
Li, W., Yin, Z., Li, X., Ma, D., Yi, S., Zhang, Z., Zou, C., Bu, K., Dai, M., Yue, J., Chen, Y., Zhang, X., & Zhang, S.
Affiliations
  • Tencent (China) (CN)
  • Ningbo University of Technology (CN)
  • China Pharmaceutical University (CN)
Corresponding author
  • Yin, Zhi
  • Zhang, Xiaojin
  • Zhang, Shengyu
Venue
Scientific Reports
Published
2024-07-23
Volume
14
Issue
1
Pages
16942-16942
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4400965811
Cited by
67
References
105
Citations by year
2026: 31 · 2025: 32 · 2024: 4
FWCI
9.89
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • arXiv (Cornell University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • arXiv (Cornell University) (cc-by)
Funders
  • National Natural Science Foundation of China (82322062)
  • Jiangsu Provincial Funds for Distinguished Young Scientists (BK20211527)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › Quantum Computing Algorithms and Architecture
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Physics and Astronomy › Atomic and Molecular Physics, and Optics › Advanced Chemical Physics Studies
Keywords
hybrid quantum computing, drug discovery, prodrug activation, Gibbs free energy, covalent bond cleavage, quantum chemistry simulation
MeSH terms
Prodrugs, Quantum Theory, Thermodynamics, Drug Design, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A hybrid quantum computing pipeline for real world drug discovery. https://app.cochat.ai/papers/10.1038/s41598-024-67897-8
The paper
Li, W., Yin, Z., Li, X., Ma, D., Yi, S., Zhang, Z., Zou, C., Bu, K., Dai, M., Yue, J., Chen, Y., Zhang, X., & Zhang, S. (2024). A hybrid quantum computing pipeline for real world drug discovery. Scientific Reports. https://doi.org/10.1038/s41598-024-67897-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.